| Tag | Content |
|---|
EnhancerAtlas ID | HS134-05091 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:224006430-224008920 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXA1 | MA0148.4 | chr1:224008133-224008149 | TCCTATGTAAACAGAA | + | 6.03 | | FOXP1 | MA0481.2 | chr1:224008137-224008149 | ATGTAAACAGAA | + | 6.92 | | FOXP2 | MA0593.1 | chr1:224008137-224008148 | ATGTAAACAGA | + | 6.02 | | Foxa2 | MA0047.2 | chr1:224008134-224008146 | CCTATGTAAACA | - | 6.92 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09755 | chr1:224007196-224009665 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 224007499 | 224008266 | | chr1 | 224008273 | 224008386 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I223819 | chr1 | 224007001 | 224008596 |
|
Enhancer Sequence | CATGCCTGGC TAATTTTTGT ATTTTACTTT AGTAGAGGCG GGGTTTCACC ATGTTGGCCA 60
GGCTGGTCTC AAACTCCTAA ACTCAGGTGA TCAACCCTCC TTGGCCTCCC AAAGTGCTGG 120
GATTATAGGC GTCAGCCACC GTGTCCGGCC AAAAATTTTT TAATTAAAAA GTTGTGCCAG 180
ATGCAGTGGC TCACACCTGT AATCCCAGCA CTTTGGGAGG CCGAGGTGGC GGATCACCTG 240
AGATAGGGAG TTCGAGACCA GCCTGACCAA CATGGAGAAA GCCCGTCTCT ACTAAAAATA 300
CAAAATTAGT TGGGCGTGGT GGCGTATGCC TGTAATCCCC AGCTACTCGG GAGGCTGAGG 360
CAGGAGAATT GCTTGAACCC AGGAGGCGGA GGTTGCAGTG AGCCGAGATC GCGCCATTGC 420
ACTCCAGTCT GGGCAACAAG AGCGAAACTC TGTCTCAAAA AAAAAAAAAA AGTTGTAAGA 480
AAGAAAATCC TTTACATGTC ATCATCACAT AGTAAAGGTT ATTAAATTCA AGTGAGCAAG 540
AGGAATAAGT GGGATCAAAA GTATCAAGGA ACAGAGTACA GCCCTGGCAA AGATAGAACA 600
CTTCTTCCTC TATGAAAATG AGAAGAAAAT GGAGACACAC AGAGAGAATC TGAGGTAAAG 660
AGTAAGAAAA CTGAGGGGCC AGGCGCGGTG GCTCACACCT GTAATCCCAG CGCTTTGGGA 720
GGCCGAGACG GGTGGATCAC GAGGTCAGGA GATCGAGACC ATCCTGGCTA ACACGGTGAA 780
ACCCTGTCTC TACTAAAAAT ACAAAAAATT AGGCGGGCAT GGGGGCGGGT GCCTGTAGTC 840
CCAGCTACTC GGGAGGCTGA GGCAGGAGAA TGGCGTGAAC CTGGGAGGCA GAGCTTTCAG 900
TGAGCCAAGA TCGCGCCACT GCACTCCAGC CTGGGCGACA GAGTGAGACT CCATCTCAAA 960
AAAAGAAAAA AGAAAACTGA GGAAGCACAC AATGGATGGT TTCAATTATC TCAGTAAAGA 1020
ATAAAGCAAG GTAATTTGCT AAATGCAAGG AGGTTACCAG GAGCAGCTAG AAGTTCATTT 1080
CCTCATTCTG CAAATATTTC TACAGCATCT ACTAGGTACA AGGCACTCCC CTTGAGCTGG 1140
GGATACAGCA GTGAACAAGA TAAACAAGGT CTCTACCCTT AAATAGTTTA CATTCTAGTG 1200
CATATGTTTG GGGCTATCAG GATAAAAGGA GCAATAAACT AATAAACACA CACAAAGAGT 1260
GACGGGCCTT CTGCAGAGGA TTACATCAGG ATGATGTAAC TGAGAACTAA CTTCATGGCT 1320
ACTTTTGGCA GGGTGCTCAG GAAAAGCCTC TCCAGAAGGA GATTAACATT TTAGCTGCAA 1380
TCCAGAAGGA ACCAGCAATG ACAGTATCTG GAGACAGAGC AATACAAACA GTGGGAATGG 1440
CTATCACCAA TGACTCTAAG GTGGGAATGA GCTTAGCATA TTCGAGAAAT ATTTTAAAAG 1500
CTGCAGGAAG AAGCAGAGAA GAAAATGGTA CCAGATAAGA GCAAAGACAA AGAATCTACA 1560
GAACTTCACA ACCTAATATT AAAAGTTTGG ATTTTATTCT AAGTGGAGGA GAAGTCGCTA 1620
GTTTTAAGCA GGAAAGTGAA ATTATCTAAT TTTCATTTTC AAAAGATCCC TTGGGCTTCT 1680
TCATGTGATT GTTCTAATCT GGTTCCTATG TAAACAGAAA AGAAAGTAAT TCGGAGACTG 1740
CAGAAGACCT TCTAGAACAT CCAACTGTAG AAAAGTTAAC CAAAGATGAA TAAAAGGACT 1800
TGCCTGAAAA GAAGTGGGGG CTCAGCTGAA GTTAGCTATC ATGAATGGCA TGAACTCAAT 1860
TAACACAGTG TGTGACTTGC TCTGGGGATA TCTGGCATCC CCAGAGGTGA AAAAGGAAAC 1920
CAGCAGGAGT TCATCCAGCC TGTGTAGGAA CAAGGCAGAA ATGATGAAAA ATTACTCCCA 1980
CATCTACCAC CTCCTATGGA GCCAAAAAGA AACCAGGCTA TCCCATTTTA GAGCTCCAAA 2040
GAACCATACA GAAGGATTGA TTTCAAGGCT TACAATAATG CCCACGAGTT CACCACTGCT 2100
GTCTGCCACT ACAGTTCCTC GACACTGAGT AGCTTCCTCT AAAAACCTAC AGAAATTGAG 2160
AGAAGGCAAA CCAGTTAGGA TGCCTCAAAT TTCTAATTAA GTAAAGCTTA CACATACAAA 2220
GACACTGTTG AGCACCATCC ACTGGACCAC AACAGCCCAG ATGACCTTTT GTATTTTATA 2280
TTGTGGTGTC TCCATTTTAT TGGAGAAAAA GAAAACCGAA AAAGACTTCA TGTATCATAC 2340
CAAAGCTGGA TCAGGAACAC TATTTCTGCC GGACGTGCTA TTCTCCAGTT TCTCCCCGGA 2400
GAAACATGAG CATTCACACA GTGCCACGTC TACAAACCAA CATTAATAGA AGACAGAAGA 2460
ACTAAAGCAC GAGGCTGTCA GCGTCTCTCA 2490
|
